Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
7.70
+0.21 (2.80%)
At close: Dec 31, 2025, 4:00 PM EST
7.87
+0.17 (2.21%)
After-hours: Dec 31, 2025, 7:18 PM EST
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $575.05 million as of December 31, 2025. Its market cap has increased by 21.27% in one year.
Market Cap
575.05M
Enterprise Value
510.37M
1-Year Change
21.27%
Ranking
Category
Stock Price
$7.70
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $575.05M, an increase of 97.75%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.93B |
| Johnson & Johnson | 499.81B |
| AbbVie | 405.95B |
| UnitedHealth Group | 301.06B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.39B |
| Novo Nordisk | 227.80B |